Cellectis S.A.
CLLS
$3.24
-$0.08-2.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.50% | 42.91% | 75.76% | 158.90% | 332.15% |
| Total Other Revenue | 1.50% | -1.05% | -13.85% | 4.49% | 8.05% |
| Total Revenue | 0.61% | 37.20% | 61.72% | 129.04% | 223.06% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.61% | 37.20% | 61.72% | 133.82% | 235.66% |
| SG&A Expenses | 7.34% | 10.68% | 3.69% | 5.82% | 17.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 79.94% | 77.82% | 24.85% | -1.79% | -31.64% |
| Total Operating Expenses | 12.12% | 10.77% | 3.58% | -3.83% | 1.75% |
| Operating Income | -28.27% | 16.61% | 44.46% | 65.82% | 48.12% |
| Income Before Tax | -12.17% | -12.17% | -85.02% | 59.01% | 26.13% |
| Income Tax Expenses | -177.36% | -243.89% | -- | 201.18% | 232.65% |
| Earnings from Continuing Operations | -10.70% | -11.07% | -83.87% | 58.15% | 25.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.70% | -11.07% | -83.87% | 58.15% | 25.23% |
| EBIT | -28.27% | 16.61% | 44.46% | 65.82% | 48.12% |
| EBITDA | -41.28% | 20.22% | 54.93% | 79.14% | 56.92% |
| EPS Basic | -10.40% | -5.95% | -80.94% | 67.13% | 49.10% |
| Normalized Basic EPS | -48.08% | -38.40% | -193.76% | 76.39% | 53.44% |
| EPS Diluted | -9.93% | -5.53% | -11.66% | 72.72% | 57.32% |
| Normalized Diluted EPS | -48.11% | -38.43% | -167.51% | 76.98% | 54.53% |
| Average Basic Shares Outstanding | 0.29% | 2.79% | 10.73% | 22.45% | 41.63% |
| Average Diluted Shares Outstanding | 0.64% | 3.14% | 2.28% | 12.15% | 27.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |